Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



‘Powerful and dangerous’ illicit medicines seized in Manchester raids

“Hundreds of thousands of doses” of suspected illegally traded drugs were seized by the UK’s medicines watchdog in Manchester this week.

Crime Products

UPDATED: Competition watchdog probes Pharmacy2U purchase of LloydsDirect

The competition authority is looking into the “assets merger” of Pharmacy2U and LloydsDirect, the UK’s two largest online pharmacies, it has revealed.

Businesses Digital

Ombudsman made ‘detailed' probe into just one pharmacy complaint last year

Only one of out almost 500 complaints received by the health ombudsman last year about pharmacies was accepted for “detailed investigation”, it has revealed.

Regulatory bodies Multiples

Patients hospitalised by fake Saxenda and Ozempic pens filled with insulin

Insulin found in fake Ozempic and Saxenda injection pens has led to patients being hospitalised with hypoglycaemic shock, the medicines watchdog has revealed.

Crime Manufacturers

Eye gels recalled due to 'possible microbial contamination', MHRA warns

The UK’s medicines watchdog has recalled some carbomer-containing eye gels amid an “ongoing” investigation into whether they are contaminated with a bacteria, it has revealed.  

Eye care Infection

UPDATED: GPhC rubberstamps plans to hike registration fees by 7.5%

The pharmacy regulator has taken the "difficult decision" to increase its fees by 7.5% across the board, it has revealed.

GPhC General Regulation

Online pharmacy chided by MHRA for advertising POM Ozempic for weight loss

The Care Pharmacy has amended its advertisements after an intervention from the medicines watchdog over its promotion of Ozempic, which is a prescription-only medicine (POM).

Medicines Regulatory bodies

‘Possible cheating’ during June registration assessment, GPhC reveals

There were five allegations of cheating during this June’s registration assessment, the General Pharmaceutical Council (GPhC) has revealed. 

Registration exam GPhC

HSCC chair ‘fearful’ of ‘disastrous’ government hub-and-spoke decision

Steve Brine has predicted that contractors “won’t like” the government’s response to its hub-and-spoke consultation.

Politicians Legal

Stop retailers from offering multi-buy paracetamol deals, RPS urges

The Royal Pharmaceutical Society (RPS) has urged the government to bring in new laws that would prevent retailers from offering multi-buy deals on paracetamol.

Medicines General Regulation

Illegally traded drugs worth ‘almost’ £5m seized in 2023, says MHRA

The medicines watchdog has revealed that more than two million medicine doses traded illegally over the internet have been seized so far this year.

Crime Digital

UPDATED: GPhC extends revalidation deadline over ‘technical issues’

The General Pharmaceutical Council (GPhC) has announced that it has extended the deadline for revalidation submissions following ongoing “technical issues” with its website.

GPhC Digital
See All